To view the PDF file, sign up for a MySharenet subscription.

MINE RESTORATION INVESTMENTS LIMITED - Related Party Acquisition, Rights Offer, Waiver of Mandatory Offer, Withdrawal of Cautionary Announcement

Release Date: 10/10/2019 17:30
Code(s): MRI     PDF:  
Wrap Text
Related Party Acquisition, Rights Offer, Waiver of Mandatory Offer, Withdrawal of Cautionary Announcement

 Incorporated in the Republic of South Africa
 (Registration No. 1987/004821/06)
 Share code: MRI
 ISIN: ZAE000164562
 (“MRI” or “the Company”)


1. Introduction

Further to the renewal of the cautionary announcement released by the Company on SENS
on 1 August 2018, MRI shareholders are advised that the Company has entered into a share
purchase agreement (“the Share Purchase Agreement”) with the shareholders of Langpan
Mining Co Proprietary Limited (“Langpan”) (“the Vendors”) in terms of which the Vendors will
dispose of their entire shareholding (100%) in Langpan for an aggregate purchase
consideration of R550 000 000, to be settled through the issue by MRI of 137 500 000 000
shares (“the Consideration Shares”) (“the Proposed Transaction”) to the Vendors.

The Company also intends to raise additional capital in order to repay existing debt through a
rights offer, details of which are set out in paragraph 3. below.

After the implementation of the Proposed Transaction, MRI will hold 100% of the shares in
Langpan, making it a subsidiary of MRI. In accordance with paragraph 10.21 to Schedule 10
of the Listings Requirements of the JSE Limited (“Listings Requirements”), MRI will ensure
that no provisions contained in the Memorandum of Incorporation (“MOI”) of Langpan will
frustrate the Company in any way from compliance with its obligations in terms of the Listings
Requirements, nor will it relieve the Company from compliance with the Listings

2. The Proposed Transaction

2.1. Description of the businesses of MRI And Langpan

MRI has been listed on the Alternative Exchange of the JSE since June 2012 and exists as a
cash shell. The Company previously held two major investments in coal fines processing and
briquetting, as well as acid mine drainage technology. Both investments were discontinued
and fully impaired due to significant operational challenges.

Langpan mines and processes chrome ore to form chrome concentrate, with a by-product
having a high concentration of Platinum Group Metals (“PGM”). On 7 August 2018 and
8 August 2018, respectively, Langpan concluded agreements with Memor Marketing
Proprietary Limited and Memor Mining Proprietary Limited (collectively, “Memor”) to acquire
the plant and machinery and the mining rights, respectively, in relation to the chrome and PGM
mining and beneficiation operations associated with Memor (collectively, “the Mining Assets”).
Langpan also concluded supply agreements on 8 October 2019 with Scutella Ventures Limited
in relation to the sale of chrome concentrate for a five-year period, including a forward sale of
chrome concentrate for a two-year period (“the Forward Sale”), on commercial terms. Langpan
has further entered into a series of inter-related financing agreements the effect of which is to
immediately monetise the Forward Sale and a portion of these proceeds will be used to settle
the purchase consideration in relation to the acquisition by Langpan of the Mining Assets.

2.2. Rationale for the Proposed Transaction

The Proposed Transaction is a first step towards MRI’s transformation into a mining house
that promotes rural investment into sustainable mining projects on an inclusive and equitable
basis. The Proposed Transaction will enable MRI to transform from a cash shell and position
itself to achieve its rural investment mandate.

2.3. Details of the Vendors and related parties

The Vendors comprise the parties named in the table below.

 Name of Vendor            % shareholding Related          Nature     of     related     party
                           in Langpan     party            relationship

 Jurgens Johannes Nel            7.9%             No       None

 Scott Austin Gaskell            6.1%             No       None

 BLM Global Partners             2.4%             No       None
 RSA (Pty) Ltd

 Disruption      Capital        53.9%            Yes       MRI Directors Mike Miller and
 Limited (“DCL”)                                           Alistair Collins collectively own
                                                           56% of DCL.

 Kianalily (Pty) Ltd             8.5%            Yes       MRI Financial Director Ulrich
                                                           Bester and his associates own
                                                           100% of Kianalily.

 Palugen (Pty) Ltd              21.2%             No       None

There are no related party relationships with Memor. The Vendors will enter into a lock-up
agreement in relation to their holdings of Consideration Shares such that they will not dispose
thereof until such time as Langpan’s obligations in terms of the Forward Sale have been fully

2.4. Effective date

The Proposed Transaction will become effective nine months from the date of signature of the
Share Purchase Agreement, being 9 October 2019, subject to the fulfilment of the conditions
precedent set out in paragraph 2.5 below.

2.5. Conditions precedent
The Proposed Transaction is conditional upon, inter alia:

-   written confirmation from the JSE that the suspension of the listing of MRI shares on the
    Alternative Exchange of the JSE has been lifted;

-   the approval of the requisite majority of MRI shareholders of the Proposed Transaction;

-   the approval by MRI shareholders of a special resolution in respect of the proposed
    amendments to the Company’s MOI described in paragraph 5. below and the filing of the
    amended MOI with the Companies and Intellectual Properties Commission (“CIPC”);

-   the approval by MRI shareholders of a special resolution authorising the issue of the
    Consideration Shares and the Rights Offer shares, as set out in paragraph 3. below, in
    terms of sections 41(1) and 41(3) of the Companies Act, 71 of 2008, as amended;

-   approval of a waiver of mandatory offer in accordance with Regulation 86(4) of the
    Companies Regulations 2011 (“Companies Regulations”) as a consequence of the fact
    that DCL will, after the implementation of the Proposed Transaction, be able to exercise
    more than 35% of all of the voting rights attached to the MRI shares, and the Takeover
    Regulation Panel providing the requisite ruling in relation thereto; and

-   approval by the JSE of the publication of the circular referred to in paragraph 7. below.

2.6. Financial information relating to Langpan

The unaudited net asset value of Langpan for the year ended 28 February 2019 was
R2 847 278 in terms of the International Financial Reporting Standards. Langpan is a shelf
company which was incorporated on 20 September 2017 for the purposes of acquiring the
Mining Assets and accordingly has not yet commenced trading.

2.7. Warranties

The Share Purchase Agreement contains warranties that are normal for a transaction of this

2.8. Classification of the Proposed Transaction

In terms of the Listings Requirements, the Proposed Transaction is classified as both a related
party transaction, as certain of the Vendors are directors of the Company or associates
thereof, and a reverse takeover.

Shareholders should note that the JSE will only permit MRI to retain its listing following the
reverse take-over if the JSE is satisfied that MRI still qualifies for a listing.

3. The Rights Offer

MRI will seek to raise approximately R13.8 million through a partially underwritten
renounceable rights offer (“the Rights Offer”) at a subscription price of 0.1 cent per Rights
Offer share, whereby Rights Offer shares will be issued simultaneously with the Consideration
The proceeds from the Rights Offer will be applied as follows:
- to fund transaction costs in relation to the Rights Offer and the Proposed Transaction; and
- to extinguish certain of MRI’s liabilities.

The launch of the Rights Offer is conditional upon the conditions precedent set out in
paragraph 2.5 above.

4. Waiver of Mandatory Offer

On implementation of the Proposed Transaction and the Rights Offer, DCL will hold 48.35%
of the MRI shares in issue. Accordingly, MRI shareholders will be asked to approve a waiver
of mandatory offer in accordance with Regulation 86(4) of the Companies Regulations (“the

5. Amendments to the MOI

In order to facilitate the Proposed Transaction and the Rights Offer, it will be necessary to
increase the authorised share capital of the Company. In addition, in order to reduce the
number of shares in issue, the Company will seek the approval of its shareholders to
consolidate its shares in a ratio of 1 consolidated MRI share for every 1 000 MRI shares
currently in issue.

6. Independent Expert Opinion
In accordance with both the Listings Requirements and Regulation 86(7) of the Companies
Regulations, an independent expert will be appointed to provide a fair and reasonable opinion
in relation to the terms of the Proposed Transaction and the Waiver.

7. Circular and notice of general meeting

A circular and Revised Listings Particulars, prepared in terms of the Listings Requirements
and containing, inter alia, details of the Proposed Transaction, the Rights Offer, the Waiver
and the amendments to the MOI, together with the report of the independent expert and a
notice of general meeting of MRI shareholders will be dispatched in due course.

8. Withdrawal of cautionary announcement

Following the release of this announcement which contains the salient information relating to
the Proposed Transaction and the Rights Offer, the cautionary announcement dated 1 August
2018 is hereby withdrawn.
10 October 2019

Designated Advisor
Questco Proprietary Limited

Legal Advisor

For further information, please contact Jennifer Stein at GGi (011-728 1363 or

Date: 10/10/2019 05:30:00
Produced by the JSE SENS Department. The SENS service is an information dissemination service administered by the JSE Limited ('JSE'). 
The JSE does not, whether expressly, tacitly or implicitly, represent, warrant or in any way guarantee the truth, accuracy or completeness of
 the information published on SENS. The JSE, their officers, employees and agents accept no liability for (or in respect of) any direct, 
indirect, incidental or consequential loss or damage of any kind or nature, howsoever arising, from the use of SENS or the use of, or reliance on,
 information disseminated through SENS.

Email this JSE Sens Item to a Friend.

Share This Story